Bone mineral density and chronic lung disease mortality: the rotterdam study.

CONTEXT Low bone mineral density (BMD) has been associated with increased all-cause mortality. Cause-specific mortality studies have been controversial. OBJECTIVE The aim of the study was to investigate associations between BMD and all-cause mortality and in-depth cause-specific mortality. DESIGN AND SETTING We studied two cohorts from the prospective Rotterdam Study (RS), initiated in 1990 (RS-I) and 2000 (RS-II) with average follow-up of 17.1 (RS-I) and 10.2 (RS-II) years until January 2011. Baseline femoral neck BMD was analyzed in SD values. Deaths were classified according to International Classification of Diseases into seven groups: cardiovascular diseases, cancer, infections, external, dementia, chronic lung diseases, and other causes. Gender-stratified Cox and competing-risks models were adjusted for age, body mass index, and smoking. PARTICIPANTS The study included 5779 subjects from RS-I and 2055 from RS-II. MAIN OUTCOME MEASUREMENTS We measured all-cause and cause-specific mortality. RESULTS A significant inverse association between BMD and all-cause mortality was found in males [expressed as hazard ratio (95% confidence interval)]: RS-I, 1.07 (1.01-1.13), P = .020; RS-II, 1.31 (1.12-1.55), P = .001); but it was not found in females: RS-I, 1.05 (0.99-1.11), P = .098; RS-II, 0.91 (0.74-1.12), P = .362. An inverse association with chronic lung disease mortality was found in males [RS-I, 1.75 (1.34-2.29), P < .001; RS-II, 2.15 (1.05-4.42), P = .037] and in RS-I in females [1.72 (1.16-2.57); P = .008], persisting after multiple adjustments and excluding prevalent chronic obstructive pulmonary disease. A positive association between BMD and cancer mortality was detected in females in RS-I [0.89 (0.80-0.99); P = .043]. No association was found with cardiovascular mortality. CONCLUSIONS BMD is inversely associated with mortality. The strong association of BMD with chronic lung disease mortality is a novel finding that needs further analysis to clarify underlying mechanisms.

[1]  K. Engelke,et al.  Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies , 2013, Annals of the rheumatic diseases.

[2]  Hao Wang,et al.  Bone mineral density and all-cause, cardiovascular and stroke mortality: a meta-analysis of prospective cohort studies. , 2013, International journal of cardiology.

[3]  E. Wouters,et al.  Vitamin D status is associated with bone mineral density and functional exercise capacity in patients with chronic obstructive pulmonary disease , 2013, Annals of medicine.

[4]  D. Lynch,et al.  Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? , 2012, Arthritis and rheumatism.

[5]  R. Toes,et al.  Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. , 2012, The Journal of clinical investigation.

[6]  V. Montori,et al.  Clinical review. Risk factors for low bone mass-related fractures in men: a systematic review and meta-analysis. , 2012, The Journal of clinical endocrinology and metabolism.

[7]  J. Smolen,et al.  Inflammatory bone loss: pathogenesis and therapeutic intervention , 2012, Nature Reviews Drug Discovery.

[8]  G. Karsenty,et al.  The contribution of bone to whole-organism physiology , 2012, Nature.

[9]  Binmiao Liang,et al.  The association of low bone mineral density with systemic inflammation in clinically stable COPD , 2012, Endocrine.

[10]  B. Make,et al.  Chronic obstructive pulmonary disease: a concise review. , 2011, The Medical clinics of North America.

[11]  M. Arfan Ikram,et al.  The Rotterdam Study: 2012 objectives and design update , 2011, European journal of epidemiology.

[12]  C. Yan,et al.  The Effects of Smoke Carcinogens on Bone , 2011, Current osteoporosis reports.

[13]  A. M. Houghton,et al.  IL-17RA Is Required for CCL2 Expression, Macrophage Recruitment, and Emphysema in Response to Cigarette Smoke , 2011, PloS one.

[14]  E. Wouters,et al.  Osteoporosis in COPD outpatients based on bone mineral density and vertebral fractures , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  D. Mellström,et al.  Low bone mineral density is associated with increased mortality in elderly men: MrOS Sweden , 2011, Osteoporosis International.

[16]  J. Gelberg,et al.  Overcoming Gaps in the Management of Chronic Obstructive Pulmonary Disease in Older Patients , 2010, Drugs & aging.

[17]  Cathleen S. Colón-Emeric,et al.  Meta-analysis: Excess Mortality After Hip Fracture Among Older Women and Men , 2010, Annals of Internal Medicine.

[18]  I. Reid,et al.  Effect of osteoporosis treatment on mortality: a meta-analysis. , 2010, The Journal of clinical endocrinology and metabolism.

[19]  J. Maurer.  Prevalence, Incidence, and Lifetime Risk for the Development of COPD in the Elderly: The Rotterdam Study , 2010 .

[20]  E. Wouters,et al.  Current status of research on osteoporosis in COPD: a systematic review , 2009, European Respiratory Journal.

[21]  Monique M. B. Breteler,et al.  The Rotterdam Study: 2016 objectives and design update , 2015, European Journal of Epidemiology.

[22]  R. Gillum,et al.  Low bone mineral density and mortality in men and women: the Third National Health and Nutrition Examination Survey linked mortality file. , 2008, Annals of epidemiology.

[23]  L. Melton,et al.  A reference standard for the description of osteoporosis. , 2008, Bone.

[24]  H Putter,et al.  Tutorial in biostatistics: competing risks and multi‐state models , 2007, Statistics in medicine.

[25]  O. Johnell,et al.  An estimate of the worldwide prevalence and disability associated with osteoporotic fractures , 2006, Osteoporosis International.

[26]  A. Hofman,et al.  Coronary Calcification Improves Cardiovascular Risk Prediction in the Elderly , 2005, Circulation.

[27]  T. Spector,et al.  The assessment of vertebral deformity: A method for use in population studies and clinical trials , 1993, Osteoporosis International.

[28]  C. Baudoin,et al.  Bone Mass Density and Risk of Breast Cancer and Survival in Older Women , 2003, European Journal of Epidemiology.

[29]  R. Gillum,et al.  Bone mineral density and mortality in women and men: the NHANES I epidemiologic follow-up study. , 2003, Annals of epidemiology.

[30]  R. Gillum,et al.  Bone Mineral Density and Stroke , 2003, Stroke.

[31]  Douglas G Altman,et al.  Quantification of the completeness of follow-up , 2002, The Lancet.

[32]  A. Hofman,et al.  Bone mineral density and mortality in elderly men and women: the Rotterdam Study. , 2002, Bone.

[33]  D. Biskobing.  COPD and osteoporosis. , 2002, Chest.

[34]  S. Cummings,et al.  Rate of Bone Loss Is Associated with Mortality in Older Women: A Prospective Study , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  H K Genant,et al.  Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group. , 1999, Archives of internal medicine.

[36]  H. Wahner,et al.  Updated Data on Proximal Femur Bone Mineral Levels of US Adults , 1998, Osteoporosis International.

[37]  R. Ziegler,et al.  Reduced Pulmonary Function in Patients with Spinal Osteoporotic Fractures , 1998, Osteoporosis International.

[38]  A. Hofman,et al.  The association between age and bone mineral density in men and women aged 55 years and over: the Rotterdam Study. , 1994, Bone and mineral.

[39]  S. Preston,et al.  Old age mortality patterns in low-mortality countries: an evaluation of population and death data at advanced ages 1950 to the present. , 1989 .

[40]  S. Soraci,et al.  Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. , 1983, Arthritis and rheumatism.